Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study
Publication
, Conference
Hsi, ED; Said, J; Johnson, JL; Jung, S; Lai, R; Jones, D; Chadburn, A; Cheson, BD; Wilson, WH
Published in: BLOOD
November 16, 2008
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
181 / 181
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hsi, E. D., Said, J., Johnson, J. L., Jung, S., Lai, R., Jones, D., … Wilson, W. H. (2008). Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study. In BLOOD (Vol. 112, pp. 181–181). San Francisco, CA: AMER SOC HEMATOLOGY.
Hsi, Eric D., Jonathan Said, Jeffrey L. Johnson, Sinho Jung, Raymond Lai, Dan Jones, Amy Chadburn, Bruce D. Cheson, and Wyndham H. Wilson. “Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study.” In BLOOD, 112:181–181. AMER SOC HEMATOLOGY, 2008.
Hsi ED, Said J, Johnson JL, Jung S, Lai R, Jones D, et al. Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study. In: BLOOD. AMER SOC HEMATOLOGY; 2008. p. 181–181.
Hsi, Eric D., et al. “Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study.” BLOOD, vol. 112, no. 11, AMER SOC HEMATOLOGY, 2008, pp. 181–181.
Hsi ED, Said J, Johnson JL, Jung S, Lai R, Jones D, Chadburn A, Cheson BD, Wilson WH. Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study. BLOOD. AMER SOC HEMATOLOGY; 2008. p. 181–181.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
181 / 181
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology